Secondary MR analyses examining the causal association of genetically determined caffeine intake from tea or coffee with TB-BMD in five age-strata.
. | Beta estimatea (95% CI) . | P-value . | MR-Egger intercept test (P-value) . | MR-PRESSO global test (P-value) . |
---|---|---|---|---|
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.118 (−0.208 to 0.444) | 0.479 | ||
Weighted median | 0.142 (−0.271 to 0.555) | 0.500 | ||
Contamination mixture | 0.12 (−0.2 to 0.44) | 0.479 | ||
MR-Egger | 0 (−0.72 to 0.72) | 1.000 | 0.719 | |
MR-PRESSO | 0.118 (−0.096 to 0.332) | 0.256 | 0.988 | |
15–30 years | ||||
IVW | 0.26 (−0.451 to 0.97) | 0.474 | ||
Weighted median | 0.394 (−0.483 to 1.27) | 0.379 | ||
Contamination mixture | 0.26 (−0.46 to 0.97) | 0.474 | ||
MR-Egger | 0.976 (−0.674 to 2.626) | 0.246 | 0.346 | |
MR-PRESSO | 0.26 (−0.114 to 0.633) | 0.148 | 0.986 | |
30–45 years | ||||
IVW | 0.311 (−0.07 to 0.692) | 0.109 | ||
Weighted median | 0.354 (−0.17 to 0.878) | 0.185 | ||
Contamination mixture | 0.31 (−0.06 to 0.69) | 0.109 | ||
MR-Egger | 0.438 (−0.428 to 1.304) | 0.321 | 0.749 | |
MR-PRESSO | 0.311 (−0.001 to 0.623) | 0.050 | 0.819 | |
45–60 years | ||||
IVW | 0.313 (0.06 to 0.566) | 0.015 | ||
Weighted median | 0.415 (0.069 to 0.762) | 0.019 | ||
Contamination mixture | 0.37 (0.08 to 0.65) | 0.017 | ||
MR-Egger | 0.184 (−0.388 to 0.756) | 0.528 | 0.622 | |
MR-PRESSO | 0.313 (0.072 to 0.554) | 0.014 | 0.722 | |
60 years or above | ||||
IVW | −0.028 (−0.273 to 0.217) | 0.824 | ||
Weighted median | −0.017 (−0.334 to 0.299) | 0.914 | ||
Contamination mixture | −0.03 (−0.27 to 0.21) | 0.824 | ||
MR-Egger | 0.071 (−0.474 to 0.616) | 0.798 | 0.69 | |
MR-PRESSO | −0.028 (−0.189 to 0.133) | 0.713 | 0.979 | |
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.199 (−0.083 to 0.48) | 0.167 | ||
Weighted median | 0.125 (−0.233 to 0.483) | 0.494 | ||
Contamination mixture | 0.2 (−0.08 to 0.48) | 0.167 | ||
MR-Egger | 0.114 (−0.454 to 0.682) | 0.695 | 0.736 | |
MR-PRESSO | 0.199 (−0.053 to 0.45) | 0.111 | 0.836 | |
15–30 years | ||||
IVW | −0.157 (−0.691 to 0.376) | 0.563 | ||
Weighted median | −0.354 (−1.137 to 0.429) | 0.376 | ||
Contamination mixture | −0.16 (−1.1 to 0.79) | 0.563 | ||
MR-Egger | −0.116 (−1.187 to 0.955) | 0.832 | 0.93 | |
MR-PRESSO | −0.157 (−0.594 to 0.279) | 0.445 | 0.693 | |
30–45 years | ||||
IVW | 0.221 (−0.106 to 0.548) | 0.186 | ||
Weighted median | 0.229 (−0.223 to 0.681) | 0.321 | ||
Contamination mixture | 0.22 (−0.1 to 0.54) | 0.186 | ||
MR-Egger | 0.261 (−0.359 to 0.88) | 0.409 | 0.881 | |
MR-PRESSO | 0.221 (−0.02 to 0.461) | 0.069 | 0.902 | |
45–60 years | ||||
IVW | 0.24 (0.008 to 0.472) | 0.043 | ||
Weighted median | 0.225 (−0.073 to 0.523) | 0.139 | ||
Contamination mixture | 0.24 (0.01 to 0.47) | 0.043 | ||
MR-Egger | 0.173 (−0.271 to 0.617) | 0.444 | 0.731 | |
MR-PRESSO | 0.24 (0.029 to 0.45) | 0.029 | 0.813 | |
60 years or above | ||||
IVW | 0.008 (−0.199 to 0.216) | 0.936 | ||
Weighted median | −0.015 (−0.288 to 0.257) | 0.911 | ||
Contamination mixture | 0.01 (−0.2 to 0.21) | 0.937 | ||
MR-Egger | −0.137 (−0.533 to 0.258) | 0.496 | 0.396 | |
MR-PRESSO | 0.008 (−0.194 to 0.211) | 0.930 | 0.718 |
. | Beta estimatea (95% CI) . | P-value . | MR-Egger intercept test (P-value) . | MR-PRESSO global test (P-value) . |
---|---|---|---|---|
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.118 (−0.208 to 0.444) | 0.479 | ||
Weighted median | 0.142 (−0.271 to 0.555) | 0.500 | ||
Contamination mixture | 0.12 (−0.2 to 0.44) | 0.479 | ||
MR-Egger | 0 (−0.72 to 0.72) | 1.000 | 0.719 | |
MR-PRESSO | 0.118 (−0.096 to 0.332) | 0.256 | 0.988 | |
15–30 years | ||||
IVW | 0.26 (−0.451 to 0.97) | 0.474 | ||
Weighted median | 0.394 (−0.483 to 1.27) | 0.379 | ||
Contamination mixture | 0.26 (−0.46 to 0.97) | 0.474 | ||
MR-Egger | 0.976 (−0.674 to 2.626) | 0.246 | 0.346 | |
MR-PRESSO | 0.26 (−0.114 to 0.633) | 0.148 | 0.986 | |
30–45 years | ||||
IVW | 0.311 (−0.07 to 0.692) | 0.109 | ||
Weighted median | 0.354 (−0.17 to 0.878) | 0.185 | ||
Contamination mixture | 0.31 (−0.06 to 0.69) | 0.109 | ||
MR-Egger | 0.438 (−0.428 to 1.304) | 0.321 | 0.749 | |
MR-PRESSO | 0.311 (−0.001 to 0.623) | 0.050 | 0.819 | |
45–60 years | ||||
IVW | 0.313 (0.06 to 0.566) | 0.015 | ||
Weighted median | 0.415 (0.069 to 0.762) | 0.019 | ||
Contamination mixture | 0.37 (0.08 to 0.65) | 0.017 | ||
MR-Egger | 0.184 (−0.388 to 0.756) | 0.528 | 0.622 | |
MR-PRESSO | 0.313 (0.072 to 0.554) | 0.014 | 0.722 | |
60 years or above | ||||
IVW | −0.028 (−0.273 to 0.217) | 0.824 | ||
Weighted median | −0.017 (−0.334 to 0.299) | 0.914 | ||
Contamination mixture | −0.03 (−0.27 to 0.21) | 0.824 | ||
MR-Egger | 0.071 (−0.474 to 0.616) | 0.798 | 0.69 | |
MR-PRESSO | −0.028 (−0.189 to 0.133) | 0.713 | 0.979 | |
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.199 (−0.083 to 0.48) | 0.167 | ||
Weighted median | 0.125 (−0.233 to 0.483) | 0.494 | ||
Contamination mixture | 0.2 (−0.08 to 0.48) | 0.167 | ||
MR-Egger | 0.114 (−0.454 to 0.682) | 0.695 | 0.736 | |
MR-PRESSO | 0.199 (−0.053 to 0.45) | 0.111 | 0.836 | |
15–30 years | ||||
IVW | −0.157 (−0.691 to 0.376) | 0.563 | ||
Weighted median | −0.354 (−1.137 to 0.429) | 0.376 | ||
Contamination mixture | −0.16 (−1.1 to 0.79) | 0.563 | ||
MR-Egger | −0.116 (−1.187 to 0.955) | 0.832 | 0.93 | |
MR-PRESSO | −0.157 (−0.594 to 0.279) | 0.445 | 0.693 | |
30–45 years | ||||
IVW | 0.221 (−0.106 to 0.548) | 0.186 | ||
Weighted median | 0.229 (−0.223 to 0.681) | 0.321 | ||
Contamination mixture | 0.22 (−0.1 to 0.54) | 0.186 | ||
MR-Egger | 0.261 (−0.359 to 0.88) | 0.409 | 0.881 | |
MR-PRESSO | 0.221 (−0.02 to 0.461) | 0.069 | 0.902 | |
45–60 years | ||||
IVW | 0.24 (0.008 to 0.472) | 0.043 | ||
Weighted median | 0.225 (−0.073 to 0.523) | 0.139 | ||
Contamination mixture | 0.24 (0.01 to 0.47) | 0.043 | ||
MR-Egger | 0.173 (−0.271 to 0.617) | 0.444 | 0.731 | |
MR-PRESSO | 0.24 (0.029 to 0.45) | 0.029 | 0.813 | |
60 years or above | ||||
IVW | 0.008 (−0.199 to 0.216) | 0.936 | ||
Weighted median | −0.015 (−0.288 to 0.257) | 0.911 | ||
Contamination mixture | 0.01 (−0.2 to 0.21) | 0.937 | ||
MR-Egger | −0.137 (−0.533 to 0.258) | 0.496 | 0.396 | |
MR-PRESSO | 0.008 (−0.194 to 0.211) | 0.930 | 0.718 |
Beta estimate is presented as SD change in TB-BMD per SD increase in genetically determined caffeine intake from tea or coffee.
Secondary MR analyses examining the causal association of genetically determined caffeine intake from tea or coffee with TB-BMD in five age-strata.
. | Beta estimatea (95% CI) . | P-value . | MR-Egger intercept test (P-value) . | MR-PRESSO global test (P-value) . |
---|---|---|---|---|
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.118 (−0.208 to 0.444) | 0.479 | ||
Weighted median | 0.142 (−0.271 to 0.555) | 0.500 | ||
Contamination mixture | 0.12 (−0.2 to 0.44) | 0.479 | ||
MR-Egger | 0 (−0.72 to 0.72) | 1.000 | 0.719 | |
MR-PRESSO | 0.118 (−0.096 to 0.332) | 0.256 | 0.988 | |
15–30 years | ||||
IVW | 0.26 (−0.451 to 0.97) | 0.474 | ||
Weighted median | 0.394 (−0.483 to 1.27) | 0.379 | ||
Contamination mixture | 0.26 (−0.46 to 0.97) | 0.474 | ||
MR-Egger | 0.976 (−0.674 to 2.626) | 0.246 | 0.346 | |
MR-PRESSO | 0.26 (−0.114 to 0.633) | 0.148 | 0.986 | |
30–45 years | ||||
IVW | 0.311 (−0.07 to 0.692) | 0.109 | ||
Weighted median | 0.354 (−0.17 to 0.878) | 0.185 | ||
Contamination mixture | 0.31 (−0.06 to 0.69) | 0.109 | ||
MR-Egger | 0.438 (−0.428 to 1.304) | 0.321 | 0.749 | |
MR-PRESSO | 0.311 (−0.001 to 0.623) | 0.050 | 0.819 | |
45–60 years | ||||
IVW | 0.313 (0.06 to 0.566) | 0.015 | ||
Weighted median | 0.415 (0.069 to 0.762) | 0.019 | ||
Contamination mixture | 0.37 (0.08 to 0.65) | 0.017 | ||
MR-Egger | 0.184 (−0.388 to 0.756) | 0.528 | 0.622 | |
MR-PRESSO | 0.313 (0.072 to 0.554) | 0.014 | 0.722 | |
60 years or above | ||||
IVW | −0.028 (−0.273 to 0.217) | 0.824 | ||
Weighted median | −0.017 (−0.334 to 0.299) | 0.914 | ||
Contamination mixture | −0.03 (−0.27 to 0.21) | 0.824 | ||
MR-Egger | 0.071 (−0.474 to 0.616) | 0.798 | 0.69 | |
MR-PRESSO | −0.028 (−0.189 to 0.133) | 0.713 | 0.979 | |
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.199 (−0.083 to 0.48) | 0.167 | ||
Weighted median | 0.125 (−0.233 to 0.483) | 0.494 | ||
Contamination mixture | 0.2 (−0.08 to 0.48) | 0.167 | ||
MR-Egger | 0.114 (−0.454 to 0.682) | 0.695 | 0.736 | |
MR-PRESSO | 0.199 (−0.053 to 0.45) | 0.111 | 0.836 | |
15–30 years | ||||
IVW | −0.157 (−0.691 to 0.376) | 0.563 | ||
Weighted median | −0.354 (−1.137 to 0.429) | 0.376 | ||
Contamination mixture | −0.16 (−1.1 to 0.79) | 0.563 | ||
MR-Egger | −0.116 (−1.187 to 0.955) | 0.832 | 0.93 | |
MR-PRESSO | −0.157 (−0.594 to 0.279) | 0.445 | 0.693 | |
30–45 years | ||||
IVW | 0.221 (−0.106 to 0.548) | 0.186 | ||
Weighted median | 0.229 (−0.223 to 0.681) | 0.321 | ||
Contamination mixture | 0.22 (−0.1 to 0.54) | 0.186 | ||
MR-Egger | 0.261 (−0.359 to 0.88) | 0.409 | 0.881 | |
MR-PRESSO | 0.221 (−0.02 to 0.461) | 0.069 | 0.902 | |
45–60 years | ||||
IVW | 0.24 (0.008 to 0.472) | 0.043 | ||
Weighted median | 0.225 (−0.073 to 0.523) | 0.139 | ||
Contamination mixture | 0.24 (0.01 to 0.47) | 0.043 | ||
MR-Egger | 0.173 (−0.271 to 0.617) | 0.444 | 0.731 | |
MR-PRESSO | 0.24 (0.029 to 0.45) | 0.029 | 0.813 | |
60 years or above | ||||
IVW | 0.008 (−0.199 to 0.216) | 0.936 | ||
Weighted median | −0.015 (−0.288 to 0.257) | 0.911 | ||
Contamination mixture | 0.01 (−0.2 to 0.21) | 0.937 | ||
MR-Egger | −0.137 (−0.533 to 0.258) | 0.496 | 0.396 | |
MR-PRESSO | 0.008 (−0.194 to 0.211) | 0.930 | 0.718 |
. | Beta estimatea (95% CI) . | P-value . | MR-Egger intercept test (P-value) . | MR-PRESSO global test (P-value) . |
---|---|---|---|---|
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.118 (−0.208 to 0.444) | 0.479 | ||
Weighted median | 0.142 (−0.271 to 0.555) | 0.500 | ||
Contamination mixture | 0.12 (−0.2 to 0.44) | 0.479 | ||
MR-Egger | 0 (−0.72 to 0.72) | 1.000 | 0.719 | |
MR-PRESSO | 0.118 (−0.096 to 0.332) | 0.256 | 0.988 | |
15–30 years | ||||
IVW | 0.26 (−0.451 to 0.97) | 0.474 | ||
Weighted median | 0.394 (−0.483 to 1.27) | 0.379 | ||
Contamination mixture | 0.26 (−0.46 to 0.97) | 0.474 | ||
MR-Egger | 0.976 (−0.674 to 2.626) | 0.246 | 0.346 | |
MR-PRESSO | 0.26 (−0.114 to 0.633) | 0.148 | 0.986 | |
30–45 years | ||||
IVW | 0.311 (−0.07 to 0.692) | 0.109 | ||
Weighted median | 0.354 (−0.17 to 0.878) | 0.185 | ||
Contamination mixture | 0.31 (−0.06 to 0.69) | 0.109 | ||
MR-Egger | 0.438 (−0.428 to 1.304) | 0.321 | 0.749 | |
MR-PRESSO | 0.311 (−0.001 to 0.623) | 0.050 | 0.819 | |
45–60 years | ||||
IVW | 0.313 (0.06 to 0.566) | 0.015 | ||
Weighted median | 0.415 (0.069 to 0.762) | 0.019 | ||
Contamination mixture | 0.37 (0.08 to 0.65) | 0.017 | ||
MR-Egger | 0.184 (−0.388 to 0.756) | 0.528 | 0.622 | |
MR-PRESSO | 0.313 (0.072 to 0.554) | 0.014 | 0.722 | |
60 years or above | ||||
IVW | −0.028 (−0.273 to 0.217) | 0.824 | ||
Weighted median | −0.017 (−0.334 to 0.299) | 0.914 | ||
Contamination mixture | −0.03 (−0.27 to 0.21) | 0.824 | ||
MR-Egger | 0.071 (−0.474 to 0.616) | 0.798 | 0.69 | |
MR-PRESSO | −0.028 (−0.189 to 0.133) | 0.713 | 0.979 | |
Exposure: Genetically determined caffeine intake from tea | ||||
Below 15 years | ||||
IVW | 0.199 (−0.083 to 0.48) | 0.167 | ||
Weighted median | 0.125 (−0.233 to 0.483) | 0.494 | ||
Contamination mixture | 0.2 (−0.08 to 0.48) | 0.167 | ||
MR-Egger | 0.114 (−0.454 to 0.682) | 0.695 | 0.736 | |
MR-PRESSO | 0.199 (−0.053 to 0.45) | 0.111 | 0.836 | |
15–30 years | ||||
IVW | −0.157 (−0.691 to 0.376) | 0.563 | ||
Weighted median | −0.354 (−1.137 to 0.429) | 0.376 | ||
Contamination mixture | −0.16 (−1.1 to 0.79) | 0.563 | ||
MR-Egger | −0.116 (−1.187 to 0.955) | 0.832 | 0.93 | |
MR-PRESSO | −0.157 (−0.594 to 0.279) | 0.445 | 0.693 | |
30–45 years | ||||
IVW | 0.221 (−0.106 to 0.548) | 0.186 | ||
Weighted median | 0.229 (−0.223 to 0.681) | 0.321 | ||
Contamination mixture | 0.22 (−0.1 to 0.54) | 0.186 | ||
MR-Egger | 0.261 (−0.359 to 0.88) | 0.409 | 0.881 | |
MR-PRESSO | 0.221 (−0.02 to 0.461) | 0.069 | 0.902 | |
45–60 years | ||||
IVW | 0.24 (0.008 to 0.472) | 0.043 | ||
Weighted median | 0.225 (−0.073 to 0.523) | 0.139 | ||
Contamination mixture | 0.24 (0.01 to 0.47) | 0.043 | ||
MR-Egger | 0.173 (−0.271 to 0.617) | 0.444 | 0.731 | |
MR-PRESSO | 0.24 (0.029 to 0.45) | 0.029 | 0.813 | |
60 years or above | ||||
IVW | 0.008 (−0.199 to 0.216) | 0.936 | ||
Weighted median | −0.015 (−0.288 to 0.257) | 0.911 | ||
Contamination mixture | 0.01 (−0.2 to 0.21) | 0.937 | ||
MR-Egger | −0.137 (−0.533 to 0.258) | 0.496 | 0.396 | |
MR-PRESSO | 0.008 (−0.194 to 0.211) | 0.930 | 0.718 |
Beta estimate is presented as SD change in TB-BMD per SD increase in genetically determined caffeine intake from tea or coffee.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.